Clinical Trial Update: Transitioning From Cyclosporine to Alefacept in Psoriasis [Phase 2]

View source ↗

Summary

This Phase 2 psoriasis trial evaluates transitioning patients from cyclosporine to alefacept; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Alefacept (Alefacept)
• CYCLOSPORINE (cyclosporine)

Snippet

Sponsor: University of Medicine and Dentistry of New Jersey | Conditions: Psoriasis | Phase 2 | Status: COMPLETED